- Country: USA
- Summary: Leveraging Extant Data To Understand Developmental Trajectories Of Late Talking Children (R21 Clinical Trial Not Allowed)
- UST Ref No: 110476111
- Deadline: 02 Oct 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: PAR-25-220
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- The Purpose Of This Notice Of Funding Opportunity (Nofo) Is To Support Research Projects That Aim To Further Understanding Of The Developmental Trajectories Of Late Talking Children By Leveraging Existing Data And Creating Open And Shared Data Resources To Aid In Identifying Patterns And Predictors Of Developmental Outcomes In Late Talking Children, And Exploring Potential Underlying Mechanisms, Risk Factors, And Sequalae.
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINLeveraging Extant Data To Understand Developmental Trajectories Of Late Talking Children (R21 Clinical Trial Not Allowed) - USA Tender
The NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for Leveraging Extant Data To Understand Developmental Trajectories Of Late Talking Children (R21 Clinical Trial Not Allowed). This tender is published on USARFP under UST Ref No: 110476111 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-10-02.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
